Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyproheptadine in cystic fibrosis
IRCT20241203063927N1Phase 2Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of cyproheptadine in cystic fibrosis (CF), sponsored by Isfahan University of Medical Sciences. Started Sep 2025; status: completed.
02
Drugs
cyproheptadine
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on IRCT20241203063927N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241203063927N1.